Page last updated: 2024-08-23

dobutamine and ascorbic acid

dobutamine has been researched along with ascorbic acid in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (70.00)29.6817
2010's2 (20.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Mak, S; Newton, GE2
Mak, S; Newton, GE; Overgaard, CB1
Hata, K; Hirata, K; Inoue, N; Masai, H; Matsumoto, D; Matsumoto, H; Otake, H; Ozawa, T; Shinke, T; Shite, J; Takaoka, H; Watanabe, S; Yokoyama, M; Yoshikawa, R1
Ragaller, M1
Almsherqi, Z; Deng, Y; Matthews, S; McLachlan, CS; Mossop, P1
Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE1

Reviews

3 review(s) available for dobutamine and ascorbic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Microcirculation in sepsis and septic shock - therapeutic options?].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2008, Volume: 43, Issue:1

    Topics: Ascorbic Acid; Dobutamine; Germany; Humans; Microcirculation; Practice Guidelines as Topic; Practice Patterns, Physicians'; Sepsis; Shock, Septic; Vasculitis; Vasodilator Agents

2008
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
    Expert review of clinical pharmacology, 2022, Volume: 15, Issue:8

    Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins

2022

Trials

2 trial(s) available for dobutamine and ascorbic acid

ArticleYear
Vitamin C augments the inotropic response to dobutamine in humans with normal left ventricular function.
    Circulation, 2001, Feb-13, Volume: 103, Issue:6

    Topics: Adrenergic beta-Agonists; Antioxidants; Ascorbic Acid; Cardiac Catheterization; Cardiotonic Agents; Coronary Disease; Coronary Vessels; Diabetes Mellitus, Type 2; Dobutamine; Drug Synergism; Female; Hemodynamics; Humans; Hypertension; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Contraction; Oxidation-Reduction; Ventricular Function, Left

2001
Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:6

    Topics: Ascorbic Acid; Blood Pressure; Cardiotonic Agents; Dobutamine; Drug Combinations; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Treatment Outcome; Ventricular Dysfunction, Left

2005

Other Studies

5 other study(ies) available for dobutamine and ascorbic acid

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure.
    American journal of physiology. Heart and circulatory physiology, 2004, Volume: 286, Issue:2

    Topics: Ascorbic Acid; Cardiotonic Agents; Dobutamine; Female; Heart; Heart Failure; History, Early Modern 1451-1600; Humans; Male; Middle Aged; Myocardial Contraction; Oxidation-Reduction; Reference Values; Ventricular Dysfunction, Left

2004
Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
    American heart journal, 2007, Volume: 154, Issue:4

    Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Cardiac Catheterization; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Reactive Oxygen Species; Thermodilution; Ventricular Function, Left

2007
Vitamin C and mitochondrial uncoupling protein in enhanced dobutamine myocardial contractility.
    American heart journal, 2008, Volume: 155, Issue:4

    Topics: Ascorbic Acid; Cardiotonic Agents; Dobutamine; Humans; Mitochondria; Myocardial Contraction; Reactive Oxygen Species; Up-Regulation

2008